Iduronidase, alpha-L- (IDUA) (N-Term) Peptide
IDUA
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits IDUA
- IDUA (Iduronidase, alpha-L- (IDUA))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- LAHVSKWNFE TWNEPDHHDF DNVSMTMQGF LNYYDACSEG LRAASPALRL
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-IDUA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- IDUA (Iduronidase, alpha-L- (IDUA))
- Synonymes
- IDA Peptide, MPS1 Peptide, 6030426D08 Peptide, alpha-L-iduronidase Peptide, MGC80842 Peptide, si:ch211-12e13.9 Peptide, IDUA Peptide, iduronidase, alpha-L- Peptide, iduronidase, alpha-L- L homeolog Peptide, alpha-L-iduronidase Peptide, IDUA Peptide, Idua Peptide, idua.L Peptide, idua Peptide, LOC5564727 Peptide
- Sujet
-
This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I).
Alias Symbols: IDUA,
Protein Size: 653 - ID gène
- 3425
- NCBI Accession
- NP_000194
- UniProt
- P35475
-
Vous êtes ici:
